Showing results (1571-1580 of 1,613) with videos related to

Sort By:
Pageof 162
Acta Haematologica|January 13, 2001
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphomaT Okamoto, Y Nishimura, S Yamada, et al.
Cancer Letters|July 14, 2000
Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in ratsM Fukutake, N Miura, M Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1998
Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosteroneK Takamiya, A Yamamoto, K Furukawa, et al.
The Review of Scientific Instruments|March 3, 2012
Wall-loss distribution of charge breeding ions in an electron cyclotron resonance ion sourceS C Jeong, M Oyaizu, N Imai, et al.
The Journal of Clinical Investigation|July 20, 1999
Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclastsH Takayanagi, T Juji, T Miyazaki, et al.
British Journal of Cancer|August 30, 2008
A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204)H Kunitoh, H Kato, M Tsuboi, et al.
Bone Marrow Transplantation|November 21, 2012
Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHDT Fujioka, H Tamaki, K Ikegame, et al.
British Journal of Cancer|March 20, 2003
L523S, an RNA-binding protein as a potential therapeutic target for lung cancerT Wang, L Fan, Y Watanabe, et al.
Bone Marrow Transplantation|April 12, 2011
Salvage haploidentical transplantation for graft failure using reduced-intensity conditioningS Yoshihara, K Ikegame, K Taniguchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 20, 2018
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus ErythematosusA Doria, W Stohl, A Schwarting, et al.
Pageof 162